The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection
Open accessAbstract
The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated that iota-carrageenan is a potent inhibitor of influenza A virus infection, most importantly also of pandemic H1N1/2009 in vitro. Consequently, we tested a commercially available nasal spray containing iota-carrageenan in an influenza A mouse infection model. Treatment of mice infected with a lethal dose of influenza A PR8/34 H1N1 virus with iota-carrageenan starting up to 48 hours post infection resulted in a strong protection of mice similar to mice treated with oseltamivir. Since alternative treatment options for influenza are rare, we conclude that the nasal spray containing iota-carrageenan is an alternative to neuraminidase inhibitors and should be tested for prevention and treatment of influenza A in clinical trials in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., Govender, S., De Kock, A., Cassim, N., Palanee, T., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61842-5 · Cited by 502
Carrageenan is a potent inhibitor of papillomavirus infection
Buck, C. B., Thompson, C. D., Roberts, J. N., Müller, M., Lowy, D. R., & Schiller, J. T. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020069 · Cited by 497
Bioconversion of red seaweed galactans: a focus on bacterial agarases and carrageenases
Michel, G., Nyval-Collen, P., Barbeyron, T., Czjzek, M., & Helbert, W. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0377-7 · Cited by 240
Cited by
Necas, J., & Bartosikova, L. (2013) · Veterinární medicína · doi:10.17221/6758-vetmed · Cited by 929
Carrageenan: Drug Delivery Systems and Other Biomedical Applications
Pacheco-Quito, E.-M., Ruiz-Caro, R., & Veiga, M.-D. (2020) · Marine Drugs · doi:10.3390/md18110583 · Cited by 420
RETRACTED: Carrageenan: A natural seaweed polysaccharide and its applications
Prajapati, V. D., Maheriya, P. M., Jani, G. K., & Solanki, H. K. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.01.067 · Cited by 383
RetractedThe Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview
Wang, W., Wang, S.-X., & Guan, H.-S. (2012) · Marine Drugs · doi:10.3390/md10122795 · Cited by 381
Carbohydrate-based drugs launched during 2000−2021
Cao, X., Du, X., Jiao, H., An, Q., Chen, R., Fang, P., Wang, J., & Yu, B. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.020 · Cited by 267
Metadata
- Authors
- Leibbrandt, A., Meier, C., König-Schuster, M., Weinmüllner, R., Kalthoff, D., Pflugfelder, B., Graf, P., Frank-Gehrke, B., Beer, M., Fazekas, T., Unger, H., Prieschl-Grassauer, E., & Grassauer, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-14
- Volume
- 5
- Issue
- 12
- Pages
- e14320
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2096178489
- Cited by
- 192
- References
- 3
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection. https://app.cochat.ai/papers/10.1371/journal.pone.0014320
- The paper
- Leibbrandt, A., Meier, C., König-Schuster, M., Weinmüllner, R., Kalthoff, D., Pflugfelder, B., Graf, P., Frank-Gehrke, B., Beer, M., Fazekas, T., Unger, H., Prieschl-Grassauer, E., & Grassauer, A. (2010). Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection. PLoS ONE. https://doi.org/10.1371/journal.pone.0014320
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.